{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:17:00Z","timestamp":1791303420754,"version":"4.1.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194401","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T13:28:49Z","timestamp":1521811729000},"page":"e0194401","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines"],"prefix":"10.1371","volume":"13","author":[{"given":"Felien T. M.","family":"Busger op Vollenbroek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine J. M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 W. A.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6190-3196","authenticated-orcid":true,"given":"Hein J.","family":"Bernelot Moens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/jid.2015.206","article-title":"Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis","volume":"135","author":"A Nast","year":"2015","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bjd.12663","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials","volume":"170","author":"J Schmitt","year":"2014","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"ref3","first-page":"451","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"A Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"ref4","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"K Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-014-2546-x","article-title":"Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: A retrospective review of discontinuation rates from a large UK cohort","volume":"33","author":"E Nikiphorou","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2133.2011.10399.x","article-title":"Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: Subanalysis of the CHAMPION study","volume":"165","author":"JH Saurat","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"D Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","article-title":"BSR & BHPR guideline for disease-modifying anti-rheumatic drug therapy (DMARD) in consultation with the British Association of Dermatologists Rheumatology and British Health Professionals in Rheumatology Standards, of Dermatologists (BAD)","author":"K Chakravarty","year":"2008","journal-title":"Rheumatology"},{"key":"ref9","unstructured":"Dutch Society for Dermatology and Venereology. Guideline Psoriasis 2011. 2011;1\u2013228. Available from: http:\/\/www.med-info.nl\/Richtlijnen\/Dermatologie\/Psoriasis.pdf<\/ext-link>"},{"key":"ref10","unstructured":"Dutch Society for Rheumatology. Methotrexate Guideline update 2011. 2011;1\u20134. Available from: http:\/\/www.nvr.nl\/wp-content\/uploads\/2014\/11\/NVR-Medicijnen-MTX-richtlijn-2009-update-2011.pdf<\/ext-link>"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1468-3083.2010.03932.x","article-title":"Assessment and management of methotrexate hepatotoxicity in psoriasis patients: Report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic","volume":"25","author":"J Barker","year":"2011","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjd.12782","article-title":"Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study","volume":"171","author":"CL Martyn-Simmons","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semarthrit.2015.05.003","article-title":"Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials","volume":"45","author":"R Conway","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","article-title":"Hepatotoxicity related to antirheumatic drugs","volume":"7","author":"GP Aithal","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/1756-185X.12416","article-title":"Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate","volume":"17","author":"A Khabbazi","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.2004.023408","article-title":"Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities","volume":"64","author":"Y Yazici","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3899\/jrheum.130738","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"41","author":"B Shea","year":"2014","journal-title":"J Rheumatol"},{"issue":"6","key":"ref18","first-page":"23","article-title":"Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation","volume":"1972","author":"SP Menting","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/rheumatology\/kep176","article-title":"Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate","volume":"48","author":"H Amital","year":"2009","journal-title":"Rheumatology"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ard.2008.101378","article-title":"Elevated liver enzyme tests among rheumatoid arthritis and psoriatic arthritis patients treated with methotrexate and\/or leflunomide","volume":"69","author":"JR Curtis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref21","article-title":"Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials","author":"J West","year":"2016","journal-title":"Plos One"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","article-title":"Effect of Folic or Folinic Acid Supplementation on the Toxicity and Efficacy of Methotrexate in Rheumatoid Arthritis","volume":"44","author":"AE van Ede","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2012.10880.x","article-title":"Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists","volume":"167","author":"EC Dupuis","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.1780360307","article-title":"Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis","volume":"36","author":"AM Walker","year":"1993","journal-title":"Arthritis Rheum"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:45:11Z","timestamp":1540205111000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194401"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nurmohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194401","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]}}}